Moffatt S

University of Auckland

1
Publications in this database

PubMed name variants: Moffatt S. Uses the same surname-and-first-initial grouping as the researcher table; matches are not verified identities.

4
Career-wide h-index · OpenAlex
(1,091 citations, 4 total works)

Career-wide Research Topics · OpenAlex

Topic counts cover the OpenAlex author’s full publication record, across all conditions.

Streptococcal Infections and Treatments (2)vaccines and immunoinformatics approaches (2)T-cell and B-cell Immunology (1)Antimicrobial Resistance in Staphylococcus (1)Pain Mechanisms and Treatments (1)

Erythromelalgia Publications

SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.

Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, et al.
Neuron •

Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing. A genome-wide linkage search followed by mutational analysis of the candidate gene SCN9A, which encodes hNa(v)1.7, identified eight missense mutations in 11 families and 2 sporadic cases. Functional analysis in vitro of three of these mutant Na(v)1.7 channels revealed a reduction in fast inactivation, leading to persistent sodium current. Other mutations in SCN9A associated with more negative activation thresholds are known to cause primary erythermalgia (PE). Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current associated with PEPD mutants, but did not affect the negative activation threshold of a PE mutant. PEPD and PE are allelic variants with distinct underlying biophysical mechanisms and represent a separate class of peripheral neuronal sodium channelopathy.